Healthcare provider profile · identity verified

Carmen M. Lebron, MD

Family Practice · BALDWIN PARK, CA · NPI 1063606200

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	594	195
Amlodipine Besylate	Amlodipine Besylate	336	117
Lisinopril	Lisinopril	323	109
Losartan Potassium	Losartan Potassium	290	97
Simvastatin	Simvastatin	267	87
Levothyroxine Sodium	Levothyroxine Sodium	230	73
Metformin Hcl	Metformin Hcl	225	74
Glipizide	Glipizide	217	68
Rosuvastatin Calcium	Rosuvastatin Calcium	176	69
Omeprazole	Omeprazole	163	69
Alendronate Sodium	Alendronate Sodium	142	52
Atenolol	Atenolol	137	51
Metoprolol Tartrate	Metoprolol Tartrate	121	46
Pantoprazole Sodium	Pantoprazole Sodium	110	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	109	35
Gabapentin	Gabapentin	105	40
Hydralazine Hcl	Hydralazine Hcl	105	39
Albuterol Sulfate Hfa	Albuterol Sulfate	97	57
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	84	28
Pradaxa	Dabigatran Etexilate Mesylate	84	18
Hydrochlorothiazide	Hydrochlorothiazide	81	26
Sertraline Hcl	Sertraline Hcl	80	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	18
Ciclopirox	Ciclopirox	70	20
Humulin N Kwikpen	Insulin Nph Human Isophane	68	20
Terazosin Hcl	Terazosin Hcl	65	23
Meloxicam	Meloxicam	64	26
Potassium Chloride	Potassium Chloride	60	24
Lorazepam	Lorazepam	57	13
Triamcinolone Acetonide	Triamcinolone Acetonide	57	34
Ozempic	Semaglutide	56	12
Escitalopram Oxalate	Escitalopram Oxalate	53	21
Trazodone Hcl	Trazodone Hcl	53	21
Ibuprofen	Ibuprofen	52	26
Pregabalin	Pregabalin	50	suppressed
Furosemide	Furosemide	46	19
Famotidine	Famotidine	43	18
Hydrocortisone	Hydrocortisone	40	23
Glipizide-Metformin	Glipizide/Metformin Hcl	38	14
Methocarbamol	Methocarbamol	38	suppressed
Alvesco	Ciclesonide	37	26
Carvedilol	Carvedilol	36	11
Cephalexin	Cephalexin	36	35
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Naproxen	Naproxen	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	16
Duloxetine Hcl	Duloxetine Hcl	34	14
Metformin Hcl Er	Metformin Hcl	33	16
Azelastine Hcl	Azelastine Hcl	32	12
Ezetimibe	Ezetimibe	31	11
Tramadol Hcl	Tramadol Hcl	30	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	28	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	27	27
Alprazolam	Alprazolam	27	suppressed
Prednisone	Prednisone	27	21
Buspirone Hcl	Buspirone Hcl	26	suppressed
Jardiance	Empagliflozin	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Amoxicillin	Amoxicillin	24	22
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Mupirocin	Mupirocin	24	suppressed
Humulin N	Insulin Nph Human Isophane	23	suppressed
Clonazepam	Clonazepam	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	21
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	12
Finasteride	Finasteride	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	15
Nitroglycerin	Nitroglycerin	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Colchicine	Colchicine	13	suppressed
Estradiol	Estradiol	13	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Risedronate Sodium	Risedronate Sodium	12	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error